UY33224A - Sales e hidratos de la 4-[(3-cloro-4-fluoro-fenil)amino]-6-(cis-4-{N-[(morf- 1 -olin-4-il)carbonil]-N-metil-amino}-ciclohexan-1-iloxi)-7-metoxi-quinazolina, uso y preparación - Google Patents

Sales e hidratos de la 4-[(3-cloro-4-fluoro-fenil)amino]-6-(cis-4-{N-[(morf- 1 -olin-4-il)carbonil]-N-metil-amino}-ciclohexan-1-iloxi)-7-metoxi-quinazolina, uso y preparación

Info

Publication number
UY33224A
UY33224A UY0001033224A UY33224A UY33224A UY 33224 A UY33224 A UY 33224A UY 0001033224 A UY0001033224 A UY 0001033224A UY 33224 A UY33224 A UY 33224A UY 33224 A UY33224 A UY 33224A
Authority
UY
Uruguay
Prior art keywords
amino
morf
cyclohexan
olin
quinazoline
Prior art date
Application number
UY0001033224A
Other languages
English (en)
Inventor
Egen Marc
Rall Werner
Santagostino Marco
Schnaubelt Juergen
Sieger Peter
Soyka Rainer
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of UY33224A publication Critical patent/UY33224A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Abstract

La presente invención se refiere a Sales e hidratos de la 4-[(3-cloro-4-fluoro-fenil)amino]-6-(cis-4-{N-[(morf- 1 -olin-4-il)carbonil]-N-metil-amino}-ciclohexan-1-iloxi)-7-metoxi-quinazolina de la fórmula (I), en donde x significa Q x H2O, x HCl o (x 0,5 HCl / x 1,5 H2O), el cual muestra propiedades farmacológicas valiosas, en particular un efecto inhibidor sobre la transducción de señales mediada por tirosina quinasas, a un procedimiento para la preparación estereoselectiva de este compuesto, en particular para la inhalación de formulaciones farmacéuticas adecuadas y su uso para el tratamiento de enfermedades, en particular enfermedades tumorales, de la hiperplasia benigna de la próstata, así como de enfermedades del pulmón y de las vías respiratorias.
UY0001033224A 2010-02-15 2011-02-14 Sales e hidratos de la 4-[(3-cloro-4-fluoro-fenil)amino]-6-(cis-4-{N-[(morf- 1 -olin-4-il)carbonil]-N-metil-amino}-ciclohexan-1-iloxi)-7-metoxi-quinazolina, uso y preparación UY33224A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10153572 2010-02-15

Publications (1)

Publication Number Publication Date
UY33224A true UY33224A (es) 2011-09-30

Family

ID=42174138

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001033224A UY33224A (es) 2010-02-15 2011-02-14 Sales e hidratos de la 4-[(3-cloro-4-fluoro-fenil)amino]-6-(cis-4-{N-[(morf- 1 -olin-4-il)carbonil]-N-metil-amino}-ciclohexan-1-iloxi)-7-metoxi-quinazolina, uso y preparación

Country Status (7)

Country Link
US (1) US20120046284A1 (es)
EP (1) EP2414338A1 (es)
JP (1) JP2012526779A (es)
AR (1) AR080176A1 (es)
TW (1) TW201139426A (es)
UY (1) UY33224A (es)
WO (1) WO2011098607A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109563083B (zh) * 2016-08-12 2020-11-10 山东轩竹医药科技有限公司 喹唑啉衍生物类酪氨酸激酶抑制剂的盐及其晶型

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA009300B1 (ru) * 2002-03-30 2007-12-28 Бёрингер Ингельхайм Фарма Гмбх Унд Ко. Кг 4-(n-фениламино)хиназолины/-хинолины в качестве ингибиторов тирозинкиназы
BRPI0619603A2 (pt) 2005-12-12 2011-10-11 Boehringer Ingelheim Int heterociclos bicìclicos, sais fisiologicamante compatìveis, medicamentos que contêm esses compostos, bem como uso e processos para produção dos heterociclos bicìclicos
WO2008049842A2 (en) * 2006-10-26 2008-05-02 Boehringer Ingelheim International Gmbh Egfr kinase inhibitor combinations for the treatment of respiratory and gastrointestinal disorders
US7741489B2 (en) * 2007-03-30 2010-06-22 Medichem S.A. Process for the synthesis of solifenacin

Also Published As

Publication number Publication date
TW201139426A (en) 2011-11-16
JP2012526779A (ja) 2012-11-01
AR080176A1 (es) 2012-03-21
EP2414338A1 (de) 2012-02-08
US20120046284A1 (en) 2012-02-23
WO2011098607A1 (de) 2011-08-18

Similar Documents

Publication Publication Date Title
CY1118969T1 (el) Ενωσεις πυριμιδινο-2-αμινης και η χρηση τους ως αναστολεις των κινασων jak
CY1124928T1 (el) Αναστολεις πυραζολυλο κινοξαλινο κινασης
CY1119705T1 (el) Νεα παραγωγα αμινοπυριμιδινης
UY33889A (es) Dimaleato de 9-[4-(3-cloro-2-fluoro-fenilamino)-7-metoxiquinazolin-6-iloxi]-1,4-diaza-espiro[5 .5]undecan-5-ona, su uso como medicamento y su preparación
EA201992128A1 (ru) Конденсированные имидазопиперидиновые ингибиторы jak
CR20150633A (es) Derivados del bipirazol como inhibidores jak
CL2008001593A1 (es) Compuestos derivados de heterociclos, antagonistas para el ccr2; y uso de los compuestos para tratar afecciones o enfermedades del tracto respiratorio, como enfermedad pulmonar obstructiva cronica y asma.
BR112018008966A2 (pt) compostos inibidores de jak quinase para o tratamento de doença respiratória
DOP2010000165A (es) 4-(4-ciano-2-tioaril) dihidropirimidinonas y su uso como inhibidores de la elastasa neutrofila humana
CY1116405T1 (el) Ν1/ν2-λακταμικοι αναστολεις ακετυλο-coa καρβοξυλασης
WO2016100347A3 (en) Small molecule inhibitors of egfr and pi3k
CL2013003051A1 (es) Compuestos derivados de pirazolo (4.3-d) pirimidinas, inhibidores de quinasa; composicion farmaceutica; y uso para el tratamiento de enfermedades y trastornos del aparato respiratorio
MX2021007268A (es) Formas solidas de acido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acetico, composiciones, y usos de las mismas.
CY1116315T1 (el) Παραγωγα κιναζολιν-4(3η)-ονης που χρησιμοποιουνται ως αναστολεις κινασης ρι3
EA201490949A1 (ru) Ингибиторы киназ
BR112015029970A2 (pt) inibidores de cinase
GEP20186885B (en) Novel compounds
EA025158B9 (ru) Гетероциклические соединения, лекарственные средства, содержащие указанные соединения, их применение и способы их получения
MA32137B1 (fr) Hétérocycles spirocycliques, médicaments contenant ces composés, leur utilisation et procédé pour leur fabrication
CR20150432A (es) Estra-1,3,5 (10), 16-tetraeno-3-carboxamidas para la inhibición de la 17b-hidroxiesteroide deshidrogenasa (akr1 c3)
CY1120084T1 (el) Oλiγονουκλεοτiδiα για τη ρυθμιση της γονιδιακης εκφρασης και οι χρησεις αυτων
BR112015029504A2 (pt) inibidores quinase
MX2013002384A (es) Compuestos quinazolina y metodos para utilizarlos.
BR112015005982A2 (pt) di-hidropirrolidino-pirimidinas como inibidores de quinase
UY32830A (es) Procedimientos para la sintesis estereoselectiva de heterocíclos bicíclicos

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20191216